The Perfect Enemy | Author: Julio Marchi | Page 373
September 18, 2025

Julio Marchi

Technology Scientist, Executive, and Entrepreneur. Specialized in Internet Products Development, Digital Security, and IT Coaching. System Engineer by degree, Musician and Writer by passion. Journalist and Magazines Publisher in a previous life (getting back to it now). Currently hosting the "Julio Marchi Speaks Out Show" on YouTube.

Ascletis Announces Dosing of 24 Healthy Subjects of the First 3 Cohorts in Multiple-Dose Escalation Phase I Clinical Trial of Oral RdRp Inhibitor ASC10 for COVID-19

--The multiple-dose escalation Phase I clinical trial will enroll 72 healthy subjects including 60 subjects in 6 dose escalation cohorts...